Clinical Trial Update: DIV-AD BARCELONA: Alzheimer's Blood-Based Biomakers for a Diverse Community

View source ↗

Summary

An update on the DIV-AD Barcelona trial evaluating blood-based biomarkers for Alzheimer's disease in a diverse population. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia
• Neurodegenerative Disease

Snippet

Sponsor: Barcelonabeta Brain Research Center, Pasqual Maragall Foundation | Conditions: Alzheimer Disease, Cognitive Dysfunction, Cognitive Disorder | Status: NOT_YET_RECRUITING